当前位置: X-MOL 学术Clin. Pharmacol. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum: Abstracts of papers, 2022 Annual Meeting
Clinical Pharmacology & Therapeutics ( IF 6.7 ) Pub Date : 2022-07-03 , DOI: 10.1002/cpt.2692


Clinical Pharmacology & Therapeutics, 111(S1): S5–S80 (2022). https://doi.org/10.1002/cpt.2521

In the original publication of the 2022 ASCPT Annual Meeting abstract supplement, the authors of P-163 noticed that the name of the research network is missing in the authors list.

The authors list for P-163 should have been displayed as follows:

J. Sinha1, K. Zimmerman2, S. Balevic2, W. Muller3, C. Hornik2, M. Rathore4, Y. Finkelstein5, J. Chen6, D. Lipscomb6, D. Gonzalez1 on behalf of the Best Pharmaceuticals for Children Act Pediatric Trials Network Steering Committee.



中文翻译:

勘误:论文摘要,2022年年会

临床药理学与治疗学111(S1):S5-S80(2022)。https://doi.org/10.1002/cpt.2521

在 2022 年 ASCPT 年会摘要增刊的原始出版物中,P-163 的作者注意到作者列表中缺少研究网络的名称。

P-163 的作者列表应显示如下:

J. Sinha 1,K. Zimmerman 2,S. Balevic 2,W. Muller 3,C. Hornik 2,M. Rathore 4,Y. Finkelstein 5,J. Chen 6,D. Lipscomb 6 ,D . Gonzalez 1代表儿童最佳药物法案儿科试验网络指导委员会。

更新日期:2022-07-03
down
wechat
bug